SPARQL
Downloads
Documentation/Help
Skip Header
Results
Your Query
Add common prefixes
DESCRIBE <http://purl.uniprot.org/SHA-384/00B9BFD814D41A0279073FAF3331921B8879E49C1606A9F4D0630EF717A3F82EC8B1DD34C9FEEC6C063C395BB999A50E>
Submit Query
Cancel
RDF/XML
NTriples
Turtle
Show query
Share
Subject
Predicate
Object
http://purl.uniprot.org/SHA-384/00B9BFD814D41A0279073FAF3331921B8879E49C1606A9F4D0630EF717A3F82EC8B1DD34C9FEEC6C063C395BB999A50E
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/00B9BFD814D41A0279073FAF3331921B8879E49C1606A9F4D0630EF717A3F82EC8B1DD34C9FEEC6C063C395BB999A50E
http://www.w3.org/2000/01/rdf-schema#comment
"two independent head and neck squamous cell carcinoma cohorts treated with or without cetuximab tumor EGFR levels were indicative of survival; tumor EGFR PY1068 levels provided prognostic information independent of total EGFR"
xsd:string
http://purl.uniprot.org/uniprot/#_2329B7E6AB1D581B29DD48D57FF9CCAD1E471514D011F77A3A033A035DE65523B90ADFAF65D5E5F9952744F0B57918B9
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
http://purl.uniprot.org/SHA-384/00B9BFD814D41A0279073FAF3331921B8879E49C1606A9F4D0630EF717A3F82EC8B1DD34C9FEEC6C063C395BB999A50E
http://purl.uniprot.org/uniprot/I3WA68
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/00B9BFD814D41A0279073FAF3331921B8879E49C1606A9F4D0630EF717A3F82EC8B1DD34C9FEEC6C063C395BB999A50E
http://purl.uniprot.org/uniprot/#_I3WA68-mappedCitation-22351687
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/00B9BFD814D41A0279073FAF3331921B8879E49C1606A9F4D0630EF717A3F82EC8B1DD34C9FEEC6C063C395BB999A50E